Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Repetto

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Clinical and Translational Medicine|October 15, 2024
Repotrectinib: Redefining the therapeutic landscape for patients with ROS1 fusion-driven non-small cell lung cancerAntoine Desilets, Matteo Repetto, Alexander Drilon
Cancer Discovery|December 2, 2024
Precision Oncology: 2024 in ReviewMatteo Repetto, Nicole Fernandez, Alexander Drilon, et al.
Drugs|July 12, 2024
RET Inhibitors in RET Fusion-Positive Lung Cancers: Past, Present, and FutureMonica F Chen, Matteo Repetto, Clare Wilhelm, et al.
Cancer|April 2, 2025
Targeting ROS1 rearrangements in non-small cell lung cancer: Current insights and future directionsAntoine Desilets, Matteo Repetto, Soo-Ryum Yang, et al.
Cancer Journal (Sudbury, Mass.)|November 16, 2022
Antibody-Drug Conjugates in Breast Cancer: What Is Beyond HER2?Eleonora Nicolò, Matteo Repetto, Luca Boscolo Bielo, et al.
Expert Review of Clinical Pharmacology|September 30, 2021
Selective FGFR/FGF pathway inhibitors: inhibition strategies, clinical activities, resistance mutations, and future directionsMatteo Repetto, Edoardo Crimini, Federica Giugliano, et al.
Cancer Treatment Reviews|May 28, 2021
Precision medicine in breast cancer: From clinical trials to clinical practiceEdoardo Crimini, Matteo Repetto, Philippe Aftimos, et al.
Pharmaceuticals (Basel, Switzerland)|September 28, 2021
Research and Clinical Landscape of Bispecific Antibodies for the Treatment of Solid MalignanciesGabriele Antonarelli, Federica Giugliano, Chiara Corti, et al.
British Journal of Cancer|March 14, 2023
The emerging role of PI3K inhibitors for solid tumour treatment and beyondCarmen Belli, Matteo Repetto, Santosh Anand, et al.
Cancers|August 26, 2023
<i>RET</i>-Altered Cancers-A Tumor-Agnostic Review of Biology, Diagnosis and Targeted Therapy ActivityAntoine Desilets, Matteo Repetto, Soo-Ryum Yang, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Clinical and Translational Medicine|October 15, 2024
Repotrectinib: Redefining the therapeutic landscape for patients with ROS1 fusion-driven non-small cell lung cancerAntoine Desilets, Matteo Repetto, Alexander Drilon
Cancer Discovery|December 2, 2024
Precision Oncology: 2024 in ReviewMatteo Repetto, Nicole Fernandez, Alexander Drilon, et al.
Drugs|July 12, 2024
RET Inhibitors in RET Fusion-Positive Lung Cancers: Past, Present, and FutureMonica F Chen, Matteo Repetto, Clare Wilhelm, et al.
Cancer|April 2, 2025
Targeting ROS1 rearrangements in non-small cell lung cancer: Current insights and future directionsAntoine Desilets, Matteo Repetto, Soo-Ryum Yang, et al.
Cancer Journal (Sudbury, Mass.)|November 16, 2022
Antibody-Drug Conjugates in Breast Cancer: What Is Beyond HER2?Eleonora Nicolò, Matteo Repetto, Luca Boscolo Bielo, et al.
Expert Review of Clinical Pharmacology|September 30, 2021
Selective FGFR/FGF pathway inhibitors: inhibition strategies, clinical activities, resistance mutations, and future directionsMatteo Repetto, Edoardo Crimini, Federica Giugliano, et al.
Cancer Treatment Reviews|May 28, 2021
Precision medicine in breast cancer: From clinical trials to clinical practiceEdoardo Crimini, Matteo Repetto, Philippe Aftimos, et al.
Pharmaceuticals (Basel, Switzerland)|September 28, 2021
Research and Clinical Landscape of Bispecific Antibodies for the Treatment of Solid MalignanciesGabriele Antonarelli, Federica Giugliano, Chiara Corti, et al.
British Journal of Cancer|March 14, 2023
The emerging role of PI3K inhibitors for solid tumour treatment and beyondCarmen Belli, Matteo Repetto, Santosh Anand, et al.
Cancers|August 26, 2023
<i>RET</i>-Altered Cancers-A Tumor-Agnostic Review of Biology, Diagnosis and Targeted Therapy ActivityAntoine Desilets, Matteo Repetto, Soo-Ryum Yang, et al.
Pageof 5